Statistics for Provectus Biopharmaceuticals, (id:11351 PVCT)
Valuation metrics
Market cap
46.74M
Enterprise value
49.49M
Trailing P/E (ttm)
-12.00
Forward P/E
PEG ratio
Price/Sales (ttm)
64.56
Price/Book (mrq)
-6.70
Enterprise Value/Revenue
68.36
Enterprise Value/EBITDA
-19.00
Overview
Shares outstanding
419.91M
Float
386.66M
Shares short
1.82M
% Held by insiders
0.08%
% Held by institutions
0.00%
Average volume (10 days)
249.95K
Average volume (90 days)
Price summary
52-Week low
0.04
52-Week high
0.22
52-Week change
-4.17%
Beta
0.58
50-Day moving average
0.10
200-Day moving average
0.14
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
April 11th, 2002
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-870.81%
Operational effectiveness
Return on assets
-131.10%
Return on equity
40.85%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-2,604,765.00
Net income to common (ttm)
-3,028,654.00
Diluted EPS (ttm)
-0.01
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
187.46K
Total cash per share (mrq)
0.00
Total debt (mrq)
2.80M
Total Debt/Equity (mrq)
-0.37
Current ratio (mrq)
12.20%
Book value per share (mrq)
-0.01
Cash flow
Cash flow statement
-2,933,294.00
Levered free cash flow (LFCF)
-3,746,721.00